Babylon Bio

Babylon Bio (Babylon Biosciences) is a San Francisco-based drug discovery and development company founded in 2023 and backed by Lux Capital. Staffed by experienced medicinal chemists and biologists with a track record of discovering FDA-approved medicines, the company develops therapeutics that rescue essential functions in the brain rather than clearing emergent pathology, leveraging a proprietary high-throughput assay platform with an early focus on neurodegenerative disease including Alzheimer's. It was surfaced as a portfolio company of Lux Capital and added to the API Evangelist network. As a private, pre-commercial biotech it publishes no public API, developer portal, or documentation surface at this time.

Babylon Bio is profiled on the APIs.io network. Tagged areas include Company, Biotech, Drug Discovery, Pharmaceuticals, and Therapeutics.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechDrug DiscoveryPharmaceuticalsTherapeuticsNeuroscienceLife SciencesAlzheimer's

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/babylon-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Website

Website

LinkedIn

Source (apis.yml)

aid: babylon-bio
name: Babylon Bio
description: Babylon Bio (Babylon Biosciences) is a San Francisco-based drug discovery and development company founded in
  2023 and backed by Lux Capital. Staffed by experienced medicinal chemists and biologists with a track record of discovering
  FDA-approved medicines, the company develops therapeutics that rescue essential functions in the brain rather than clearing
  emergent pathology, leveraging a proprietary high-throughput assay platform with an early focus on neurodegenerative disease
  including Alzheimer's. It was surfaced as a portfolio company of Lux Capital and added to the API Evangelist network. As
  a private, pre-commercial biotech it publishes no public API, developer portal, or documentation surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/babylon-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lux-capital
x-tier: stub
x-tier-reason: portfolio-lead
x-enrichment-status: 'no-api-surface: identity-only biotech; verified no public API/docs/well-known as of 2026-07-18'
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/660078e1a7370d500b5e719d/67e99045ff17f5c0923513db_babylon_hero.webp
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech
- Drug Discovery
- Pharmaceuticals
- Therapeutics
- Neuroscience
- Life Sciences
- Alzheimer's
apis: []
common:
- type: Website
  url: https://babylon.bio
- type: LinkedIn
  url: https://www.linkedin.com/company/babylon-bio/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence